EXOSENS Stock: 7.64% Increase Over the Past Week
EXOSENS stock closed the week on January 3, 2026, at a price of €50.00, marking a 7.64% increase from the previous close. This performance significantly outperforms the gains of the CAC 40 (+1.13%) and the SBF 120 (+1.14%) over the same period. Over the year, the stock has risen by 157.3%, highlighting sustained momentum.
Weekly Performance Overview
The EXOSENS stock price settled at €50.00 at the last closing, up 7.64% over the past week. This weekly increase is part of a context where the stock also gained 0.63% over the last five trading days, according to intraday data from Euronext Paris. The recent opening was at €46.50, with a high of €47.20 and a low of €45.60, and a volume of 47,869 shares traded. Over the week, this positive change of 7.64% exceeds the moderate advances of the main Parisian indices: the CAC 40 progressed by 1.13%, while the SBF 120 recorded a 1.14% increase. In the longer term, the annual performance reaches 157.3%, confirming an upward trajectory since the beginning of the year, with a gain of 144.73% since January 1 according to historical data. The data show a one-month volatility of 13.78, reflecting moderate movements in a dynamic weekly framework. The beta of -0.09 indicates a low correlation with the general market, with the stock often moving independently of broader trends. Over one month, the increase amounts to 10.07%, and over three months to 18.58%, while the last six months show a +38.43% increase. These figures position EXOSENS among resilient values, with a capitalization reflecting its persistent attractiveness. The resistance threshold is at €50.00, coinciding with the current close, while support is at €41.00. This week, the stock tested higher levels, moving from a weekly low around €43.35 to highs close to €49.10 at the end of December, before consolidating towards €50.00. The annual performance of 157.3% far exceeds the benchmark indices, illustrating a strong growth in valuation.
Technical Analysis and Market Position
EXOSENS stock is trading above its 50-day moving average, set at €45.97, and its 200-day moving average at €41.27, indicating a bullish position on both short and long-term horizons. The MACD line is at 0.96, in a positive zone, while the RSI indicator is at 56, in a neutral range without excessive momentum. The upper and lower Bollinger bands frame the price between €50.18 and €43.52, with the stock thus close to the upper limit of this volatility indicator. These technical elements depict a scenario where the price consolidates its recent gains at the resistance threshold of €50.00. The support at €41.00 remains distant, providing leeway in case of a decline. Over the last five days of December, the stock fluctuated between a low of €43.35 and a high of €49.10, with a change of +5.17%, foreshadowing the weekly improvement observed. The 20-day moving average is at €45.06 and the 50-day at €45.93, confirming that the current price surpasses these sliding references. The 14-day RSI is established at 51.58, corroborating stability without overheating. These indicators converge towards an ascending technical structure, with the price solidly anchored above key moving averages and within an upward-stretched Bollinger envelope.
Market Leadership and Sector Performance
In the 2025 SBF 120 rankings, EXOSENS holds the fifth position with a performance of +149.4%, standing out among the leaders in the defense and optronics sector. This position reflects a year of strong progression, alongside other values like Exail Technologies. Historical data show annual highs at €53.00 and lows at €0.00, framing controlled volatility. Over the past week, the increase of 7.64% builds on this annual momentum, with the price now set at €50.00. The technical thresholds of support and resistance mark the path, with the stock navigating near the upper boundary.
